阿梅雷斯克 AMRC 深 滬
已收盤 10-17 16:00:00 美东时间
39.93
-2.680
-6.29%
華盛通- 最 高42.12
- 今 開41.37
- 成交量 164.23万股
- 最 低 39.71
- 昨 收 42.61
- 總市值 21.04亿
- 52周最高 44.93
- 市盈率 靜 37.46
- 換手率 3.12%
- 52周最低 8.4944
- 委 比 57.89%
- 總股本 5270.37万
- 歷史最高 101.86
- 量 比 2.05
- 振 幅 5.66%
- 歷史最低 3.91
- 每 手 1
- 風險率 7.93%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ameresco Collaborates With US NRL To Execute $197M Energy Savings Performance Contract Through USACE, Huntsville ESPC III Multiple Award Task Order Contract
ESPC Project to Modernize Infrastructure, Strengthen Mission Readiness, and Deliver Significant Cost SavingsAmeresco, Inc., (NYSE:AMRC), a leading energy solutions provider dedicated to helping customers navigate the
10-07 04:15
Terra Innovatum Partners with Ameresco to Jointly Pursue Public-Private Commercial Opportunities in the U.S. and Global Markets to Deploy SOLO Micro-Modular Reactors
Terra Innovatum and Ameresco partner to deploy 50 SOLO™ micro-modular nuclear reactors across U.S. federal and commercial sites, leveraging Ameresco's expertise and network. The collaboration aims to accelerate the commercial rollout of SOLO™ reactors, which provide safe, scalable, and carbon-free energy solutions for various applications, including power generation and industrial processes. The reactors are designed for rapid deployment and offe...
09-29 12:00
美股大行评级 | 星展银行上调百度评级至"买入"，目标价177美元；多家机构上调Guardant Health(GH)目标价最高至80美元
今日重点评级关注：Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12美元升至12.5美元；Oppenheimer：维持Immuneering"跑赢大市"评级，目标价从21美元升至30美元
09-26 09:45
Ameresco, Lithium Americas, Kodiak Sciences And Other Big Stocks Moving Higher On Thursday
U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Thursday.
09-25 22:34
Jefferies Upgrades Ameresco to Buy, Raises Price Target to $39
Jefferies analyst Julien Dumoulin-Smith upgrades Ameresco (NYSE: AMRC) from Hold to Buy and raises the price target from $19 to $39.
09-25 19:08
美股大行评级 | 最高400美元！大行纷纷连夜上调甲骨文目标价；新思科技则惨遭多家大行下调目标价
今日重点评级关注：瑞银：上调Gossamer Bio评级至"买入"，目标价从1.25美元升至9美元；Canaccord Genuity：维持Corcept Therapeutics"买入"评级，目标价从137美元升至140美元
09-11 10:06
Where Ameresco Stands With Analysts
Ameresco (NYSE:AMRC) has been analyzed by 4 analysts in the last three months, ...
09-10 21:01
B. Riley Securities Maintains Buy on Ameresco, Raises Price Target to $32
B. Riley Securities analyst Christopher Souther maintains Ameresco (NYSE:AMRC) with a Buy and raises the price target from $22 to $32.
09-10 20:20
FuelCell Energy Q3 FY2025 Earnings Call Transcript
Here is the FuelCell Energy Q3 FY2025 earnings call transcript.
09-10 00:32
FuelCell Energy CEO Points To Carbonate Tech As Key To Future Profitability
FuelCell Energy (NASDAQ: FCEL) reported Q3 fiscal 2025 results with $46.7M revenue, up 97% but below analyst expectations. Net loss widened to $92.5M.
09-09 21:49
